• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氟尿嘧啶在人体内的药代动力学。

Pharmacokinetics of fluorouracil in humans.

作者信息

MacMillan W E, Wolberg W H, Welling P G

出版信息

Cancer Res. 1978 Oct;38(10):3479-82.

PMID:688233
Abstract

A high-pressure liquid chromatography method has been used to investigate the pharmacokinetics of fluorouracil after single i.v. doses to patients. The method is simple and is specific for fluorouracil. No interference was observed in fluorouracil determinations due to other administered medication. Plasma levels of fluorouracil declined rapidly after dosing. The mean half-life was 11.4 min, and drug was essentially cleared from plasma in 1 hr. Individual differences in plasma fluorouracil levels, and also in derived pharmacokinetic constants, were considerably less than those reported previously.

摘要

已采用高压液相色谱法研究氟尿嘧啶单次静脉注射给药后在患者体内的药代动力学。该方法简单且对氟尿嘧啶具有特异性。在测定氟尿嘧啶时未观察到其他给药药物的干扰。给药后氟尿嘧啶的血浆水平迅速下降。平均半衰期为11.4分钟,药物在1小时内基本从血浆中清除。血浆氟尿嘧啶水平以及推导的药代动力学常数的个体差异明显小于先前报道的差异。

相似文献

1
Pharmacokinetics of fluorouracil in humans.氟尿嘧啶在人体内的药代动力学。
Cancer Res. 1978 Oct;38(10):3479-82.
2
Disposition of 5-fluorouracil after intravenous bolus doses of a commercial formulation to cancer patients.癌症患者静脉推注商用制剂后5-氟尿嘧啶的处置情况。
Cancer Res. 1977 Nov;37(11):3981-4.
3
Phase I and pharmacokinetic studies of high-dose uridine intended for rescue from 5-fluorouracil toxicity.
Cancer Res. 1984 Dec;44(12 Pt 1):5928-33.
4
Comparison of 5-fluorouracil pharmacokinetics in whole blood, plasma, and red blood cells in patients with colorectal cancer.结直肠癌患者全血、血浆和红细胞中5-氟尿嘧啶药代动力学的比较。
Pharmacotherapy. 1997 Sep-Oct;17(5):881-6.
5
A pharmacokinetic-based test to prevent severe 5-fluorouracil toxicity.一项基于药代动力学的试验,用于预防严重的5-氟尿嘧啶毒性。
Clin Pharmacol Ther. 2006 Oct;80(4):384-95. doi: 10.1016/j.clpt.2006.06.007.
6
Comparative pharmacokinetic analysis of 5-fluorouracil and its major metabolite 5-fluoro-5,6-dihydrouracil after conventional and reduced test dose in cancer patients.癌症患者常规剂量和减少试验剂量后5-氟尿嘧啶及其主要代谢物5-氟-5,6-二氢尿嘧啶的比较药代动力学分析
Clin Cancer Res. 2000 Aug;6(8):3032-7.
7
Pharmacokinetics of 5-fluorouracil after short systemic infusion: plasma level at the end of the distribution phase as an indicator of the total area under the plasma concentration-time curve.短时间全身输注后5-氟尿嘧啶的药代动力学:分布相结束时的血浆水平作为血浆浓度-时间曲线下总面积的指标。
Ther Drug Monit. 1991 Mar;13(2):96-102.
8
Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.接受持续5-氟尿嘧啶输注的患者与口服尿嘧啶加N1-(2'-四氢呋喃基)-5-氟尿嘧啶患者的5-氟尿嘧啶药代动力学比较。
Clin Cancer Res. 1998 Sep;4(9):2085-8.
9
Steady-state nonlinear pharmacokinetics of 5-fluorouracil during hepatic arterial and intravenous infusions in cancer patients.癌症患者肝动脉输注和静脉输注5-氟尿嘧啶时的稳态非线性药代动力学
Cancer Res. 1986 Mar;46(3):1499-506.
10
Altered plasma kinetics of 5-FU at high dosage in rat and man.大鼠和人体中高剂量5-氟尿嘧啶的血浆动力学改变。
Cancer Treat Rep. 1985 Jan;69(1):133-6.

引用本文的文献

1
An automated pipeline to generate initial estimates for population Pharmacokinetic base models.一种用于生成群体药代动力学基础模型初始估计值的自动化流程。
J Pharmacokinet Pharmacodyn. 2025 Nov 6;52(6):60. doi: 10.1007/s10928-025-10000-z.
2
Construction of Dynamic Hydrogel Inducing Effective and Selective 5-Fluorouracil Monotherapy against Cervical Cancer Cells.构建动态水凝胶以诱导对宫颈癌细胞进行有效且选择性的5-氟尿嘧啶单一疗法
ACS Appl Mater Interfaces. 2025 Mar 5;17(9):13427-13444. doi: 10.1021/acsami.4c20276. Epub 2025 Feb 21.
3
5-Fluorouracil-methotrexate conjugate enhances the efficacy of 5-fluorouracil in colorectal cancer therapy.
5-氟尿嘧啶-甲氨蝶呤共轭物增强了5-氟尿嘧啶在结直肠癌治疗中的疗效。
Invest New Drugs. 2025 Feb;43(1):30-41. doi: 10.1007/s10637-024-01488-2. Epub 2024 Dec 21.
4
Formulation and pharmacokinetics of thermosensitive stealth® liposomes encapsulating 5-Fluorouracil.包封5-氟尿嘧啶的热敏隐形脂质体的制剂与药代动力学
Pharm Res. 2015 May;32(5):1585-603. doi: 10.1007/s11095-014-1559-0. Epub 2014 Nov 22.
5
Ultrasound-activated agents comprised of 5FU-bearing nanoparticles bonded to microbubbles inhibit solid tumor growth and improve survival.超声激活剂由结合了微泡的载有 5FU 的纳米粒子组成,可抑制实体瘤生长并提高存活率。
Mol Ther. 2014 Feb;22(2):321-328. doi: 10.1038/mt.2013.259. Epub 2013 Oct 31.
6
Phenotypic profiling of DPYD variations relevant to 5-fluorouracil sensitivity using real-time cellular analysis and in vitro measurement of enzyme activity.采用实时细胞分析和体外酶活性测定对与 5-氟尿嘧啶敏感性相关的 DPYD 变异进行表型谱分析。
Cancer Res. 2013 Mar 15;73(6):1958-68. doi: 10.1158/0008-5472.CAN-12-3858. Epub 2013 Jan 17.
7
5-Fluorouracil: forty-plus and still ticking. A review of its preclinical and clinical development.5-氟尿嘧啶:四十余载仍在发挥作用。其临床前及临床开发综述
Invest New Drugs. 2000 Nov;18(4):299-313. doi: 10.1023/a:1006416410198.
8
Resection of locally advanced pancreatic cancer after downstaging with continuous-infusion 5-fluorouracil, mitomycin-C, leucovorin, and dipyridamole.经持续输注5-氟尿嘧啶、丝裂霉素-C、亚叶酸钙和双嘧达莫进行降期后对局部进展期胰腺癌进行切除术。
J Gastrointest Surg. 1998 Mar-Apr;2(2):159-66. doi: 10.1016/s1091-255x(98)80008-5.
9
Preoperative therapy for advanced pelvic malignancy by isolated pelvic perfusion with the balloon-occlusion technique.采用球囊阻断技术经盆腔隔离灌注对晚期盆腔恶性肿瘤进行术前治疗。
Ann Surg Oncol. 1996 May;3(3):295-303. doi: 10.1007/BF02306286.
10
Antitumor effect of intratumoral administration of fluorouracil/epinephrine injectable gel in C3H mice.氟尿嘧啶/肾上腺素注射用凝胶瘤内给药对C3H小鼠的抗肿瘤作用。
Cancer Chemother Pharmacol. 1995;36(1):27-34. doi: 10.1007/BF00685728.